JX44
Quality HealthCare 2021-2022 Quadrivalent Influenza Vaccine
Recommended for
- Recommended for 13 years old or above
* Limited offer till 31 December 2021.
* Customers are required to take the vaccination before 28 February 2022.
Vaccination
-
2021-2022 Quadrivalent Influenza Vaccine
-
Injection procedure is handled by medical professional
Every year, whenever the peak influenza season comes, there will be a number of influenza cases. Therefore, besides of children has a need to receive vaccination, it is recommended that teenagers and adults are also need to receive seasonal influenza vaccination to reduce the admission rates and death cases due to influenza-associated complications. In addition, the apparent symptoms of COVID-19 and influenza are similar. Both illnesses cause respiratory tract diseases, including fever, runny nose and sore throat, so it is difficult to distinguish between COVID-19 and influenza according to merely the clinical symptoms. As a result, even though children go out less often during the COVID-19 epidemic, parents should still stay alert.
Vaccination is one of the most effective ways to prevent seasonal influenza and associated complications, so people aged 6 months or above should receive seasonal influenza vaccination. For children under 9 years of age who have never received such vaccination before are recommended to receive 2 doses of seasonal influenza vaccination in the 2020-21 season.
New influenza strains appear from time to time and at irregular intervals. As the vaccine composition is updated every year in accordance with the circulating strains, it is suggested that people should receive seasonal influenza vaccination annually. After vaccination, it takes around two weeks for the body to develop antibodies to prevent the disease. Therefore, seasonal influenza vaccine should be given at least two weeks before the beginning of influenza season for proper protection during the influenza season.
The quadrivalent influenza vaccines (Northern Hemisphere winter disease) recommended by the World Health Organization (WHO) for the 2021-22 season contain the following:
- A/Victoria/2570/2019 (H1N1) pdm09-like virus
- A/Cambodia/e0826360/2020 (H3N2)-like virus
- B/Washington/02/2019 (B/Victoria lineage)-like virus
- B/Phuket/3073/2013 (B/Yamagata lineage)-like virus
Product Details:
- Intramuscular injection of inactivated influenza vaccine
- Individuals 13 years old or above: Single dose
Remarks:
If you have any of the following conditions, you are recommended to seek advice before receiving vaccination.
- Suffer from any acute, chronic or severe illness or any illness (with or without fever) e.g. upper respiratory tract infection, common cold
- Allergic to any vaccine components, including egg white, chicken protein, gentamicin sulphate, neomycin, formaldehyde (preservative), haemagglutinin, etc.
- Allergy or serious reaction to drug or vaccine in the past
- Blood disorder e.g. thrombocytopenia, coagulation disorder
- Immunocopromised
Terms and Conditions:
- Customers are required to take the vaccination during the vaccination period (8 September 2021 – 28 February 2022).
- Customers must present their identity card, order confirmation letter (printed or e-version) and completed consent form to the designated clinic for verification before vaccination.
- The product is applicable to individuals aged 13 and above (age as at the date of vaccination)
- Individuals aged below 18 (age as at the date of vaccination) MUST be accompanied by their parents/guardians, who will sign on the consent form on behalf of the enrolees in the clinic.
- Should a doctor assessment be required or requested (including adult or child of any age), an additional fee of HK$100 will be charged.
- Offers cannot be used in conjunction with any other promotional offers or discounts and cannot be exchanged for cash or other products.
- Neither amendment nor cancellation is allowed once the payment has been confirmed. Also, it is not transferable nor refundable.
- All vaccinations are not for the purpose of medical diagnosis or treatment.
- In case of disputes, the decision of ESD Service Limited & Quality HealthCare Medical Services Limited shall be final.